MedTech Europe’s Bisazza Urges Action As US Tariffs Jeopardize Critical Global Supply Chains
The Trump tariffs threaten to unleash unprecedented trade chaos.
The intricate assembly of medical devices, often involving over 1,000 globally sourced components, faces severe disruption due to new US tariffs. These barriers could halt production and devastate small and medium-sized enterprises (SMEs), MedTech Europe’s CEO, Oliver Bisazza, warns in an interview with Medtech Insight.
